newsfilter
← Latest News
PR Newswire·

Inhibrx Announces Participation in Upcoming Scientific Conferences

Inhibrx, Inc. (Nasdaq: INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, ...